{"id":277640,"date":"2024-10-19T18:41:51","date_gmt":"2024-10-19T18:41:51","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-5840-32013\/"},"modified":"2024-10-25T15:12:45","modified_gmt":"2024-10-25T15:12:45","slug":"bs-en-iso-5840-32013","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-5840-32013\/","title":{"rendered":"BS EN ISO 5840-3:2013"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
5<\/td>\n | Annex ZA (informative) Relationship between this European Standard and the Essential Requirements of EU Directive 93\/42\/EEC <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | Section sec_1 Section sec_2 1\tScope 2\tNormative references <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | Section sec_3 3\tTerms and definitions <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | Table tab_a Figure fig_1 <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | Table tab_c Figure fig_2 <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | Section sec_4 Section sec_5 Section sec_6 Section sec_6.1 Section sec_6.2 Section sec_6.2.1 4\tAbbreviations 5\tFundamental requirements 6\tDevice description 6.1\tIntended use 6.2\tDesign inputs <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | Table tab_1 Table tab_2 <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | Section sec_6.2.2 Section sec_6.2.2.1 Section sec_6.2.2.2 <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | Section sec_6.2.2.3 Section sec_6.2.3 Section sec_6.2.4 Section sec_6.3 Section sec_6.4 6.3\tDesign outputs 6.4\tDesign transfer (manufacturing verification\/validation) <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | Section sec_6.5 Section sec_7 Section sec_7.1 Section sec_7.2 Section sec_7.2.1 Section sec_7.2.1.1 Section sec_7.2.1.2 Section sec_7.2.1.3 Section sec_7.2.1.4 Section sec_7.2.1.5 6.5\tRisk management 7\tDesign verification testing and analysis\/design validation 7.1\tGeneral requirements 7.2\tIn vitro assessment <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | Section sec_7.2.1.6 Section sec_7.2.2 Section sec_7.2.2.1 Section sec_7.2.2.2 Section sec_7.2.2.3 <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | Section sec_7.2.3 Table tab_3 <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | Table tab_4 <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | Section sec_7.2.4 Section sec_7.2.4.1 Section sec_7.2.4.2 <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | Section sec_7.2.4.3 Section sec_7.2.5 Section sec_7.2.5.1 <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | Section sec_7.2.5.2 Section sec_7.2.5.3 Section sec_7.2.5.4 Section sec_7.2.5.5 Section sec_7.2.5.6 Section sec_7.2.5.7 Section sec_7.2.5.8 Section sec_7.2.6 <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | Section sec_7.2.6.1 Section sec_7.2.6.2 Section sec_7.2.6.3 <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | Section sec_7.2.7 Section sec_7.2.8 Section sec_7.2.9 Section sec_7.2.10 <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | Section sec_7.3 Section sec_7.3.1 7.3\tPreclinical in vivo evaluation <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | Section sec_7.3.2 <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | Section sec_7.3.3 <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | Section sec_7.4 Section sec_7.4.1 Section sec_7.4.2 7.4\tClinical investigations <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | Section sec_7.4.3 Section sec_7.4.4 Section sec_7.4.5 Section sec_7.4.6 Section sec_7.4.7 Section sec_7.4.7.1 <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | Section sec_7.4.7.2 Section sec_7.4.7.3 <\/td>\n<\/tr>\n | ||||||
39<\/td>\n | Section sec_7.4.7.4 Section sec_7.4.8 Section sec_7.4.8.1 <\/td>\n<\/tr>\n | ||||||
40<\/td>\n | Section sec_7.4.8.2 Section sec_7.4.8.3 <\/td>\n<\/tr>\n | ||||||
41<\/td>\n | Annex sec_A Annex sec_A.1 Annex sec_A.2 Annex\u00a0A \n(informative)<\/p>\n Rationale for the provisions of this part of ISO\u00a05840 <\/td>\n<\/tr>\n | ||||||
42<\/td>\n | Annex sec_A.3 Annex sec_A.4 Annex sec_A.5 <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | Annex sec_A.6 Annex sec_A.7 <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | Annex sec_B Annex sec_B.1 Figure fig_B.1 Annex\u00a0B \n(informative)<\/p>\n Examples of transcatheter heart valve substitutes, components and delivery systems <\/td>\n<\/tr>\n | ||||||
45<\/td>\n | Figure fig_B.2 Table tab_g Figure fig_B.3 <\/td>\n<\/tr>\n | ||||||
46<\/td>\n | Table tab_h Figure fig_B.4 Figure fig_B.5 <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | Table tab_i Figure fig_B.6 Annex sec_B.2 Figure fig_B.7 <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | Table tab_j Figure fig_B.8 Figure fig_B.9 Figure fig_B.10 <\/td>\n<\/tr>\n | ||||||
49<\/td>\n | Figure fig_B.11 <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | Annex sec_C Annex sec_C.1 Annex sec_C.2 Annex sec_C.3 Annex sec_C.3.1 Annex sec_C.3.2 Annex\u00a0C \n(normative)<\/p>\n Packaging <\/td>\n<\/tr>\n | ||||||
51<\/td>\n | Annex sec_D Annex sec_D.1 Annex sec_D.1.1 Annex sec_D.1.2 Annex\u00a0D \n(normative)<\/p>\n Product labels, instructions for use and training <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | Annex sec_D.1.3 <\/td>\n<\/tr>\n | ||||||
53<\/td>\n | Annex sec_D.1.4 Annex sec_D.2 <\/td>\n<\/tr>\n | ||||||
54<\/td>\n | Annex sec_E Annex sec_E.1 Annex\u00a0E \n(normative)<\/p>\n Sterilization <\/td>\n<\/tr>\n | ||||||
55<\/td>\n | Annex sec_F Annex sec_F.1 Annex sec_F.2 Annex sec_F.3 Annex\u00a0F \n(informative)<\/p>\n Valve description <\/td>\n<\/tr>\n | ||||||
56<\/td>\n | Annex sec_F.4 Annex sec_F.5 Annex sec_F.6 <\/td>\n<\/tr>\n | ||||||
57<\/td>\n | Annex sec_G Annex sec_G.1 Table tab_G.1 Annex\u00a0G \n(informative)<\/p>\n Transcatheter heart valve substitute hazards, associated failure modes and evaluation methods <\/td>\n<\/tr>\n | ||||||
58<\/td>\n | Annex sec_G.2 <\/td>\n<\/tr>\n | ||||||
60<\/td>\n | Annex sec_G.3 <\/td>\n<\/tr>\n | ||||||
61<\/td>\n | Annex sec_H Annex sec_H.1 Table tab_H.1 Annex sec_H.2 Table tab_H.2 Annex sec_H.3 Annex\u00a0H \n(informative)<\/p>\n In vitro test guidelines for paediatric devices <\/td>\n<\/tr>\n | ||||||
62<\/td>\n | Table tab_H.3 Annex sec_H.4 Table tab_H.4 Annex sec_H.5 Table tab_H.5 Annex sec_H.6 <\/td>\n<\/tr>\n | ||||||
63<\/td>\n | Table tab_H.6 Annex sec_H.7 Table tab_H.7 Annex sec_H.8 Table tab_H.8 Annex sec_H.9 <\/td>\n<\/tr>\n | ||||||
64<\/td>\n | Table tab_H.9 <\/td>\n<\/tr>\n | ||||||
65<\/td>\n | Annex sec_I Annex sec_I.1 Annex sec_I.2 Annex\u00a0I \n(informative)<\/p>\n Statistical procedures when using performance criteria <\/td>\n<\/tr>\n | ||||||
66<\/td>\n | Annex sec_J Annex sec_J.1 Annex sec_J.2 Annex\u00a0J \n(informative)<\/p>\n Examples and definitions of some physical and material properties of transcatheter heart valve substitutes and their components <\/td>\n<\/tr>\n | ||||||
67<\/td>\n | Annex sec_J.3 Annex sec_J.3.1 <\/td>\n<\/tr>\n | ||||||
68<\/td>\n | Annex sec_J.4 Annex sec_J.4.1 <\/td>\n<\/tr>\n | ||||||
72<\/td>\n | Annex sec_J.5 <\/td>\n<\/tr>\n | ||||||
73<\/td>\n | Table tab_k Figure fig_J.1 <\/td>\n<\/tr>\n | ||||||
75<\/td>\n | Table tab_l Figure fig_J.2 <\/td>\n<\/tr>\n | ||||||
77<\/td>\n | Table tab_m Figure fig_J.3 <\/td>\n<\/tr>\n | ||||||
79<\/td>\n | Annex sec_K Annex sec_K.1 Annex\u00a0K \n(informative)<\/p>\n Examples of standards applicable to testing of materials and components of transcatheter heart valve substitutes <\/td>\n<\/tr>\n | ||||||
81<\/td>\n | Annex sec_K.2 <\/td>\n<\/tr>\n | ||||||
83<\/td>\n | Annex sec_K.3 Annex sec_K.4 Annex sec_K.5 Annex sec_K.6 <\/td>\n<\/tr>\n | ||||||
85<\/td>\n | Annex sec_L Annex sec_L.1 Annex sec_L.2 Annex sec_L.3 Annex\u00a0L \n(informative)<\/p>\n Raw and post-conditioning mechanical properties for support structure materials <\/td>\n<\/tr>\n | ||||||
87<\/td>\n | Annex sec_M Annex sec_M.1 Annex sec_M.2 Annex sec_M.3 Annex\u00a0M \n(informative)<\/p>\n Corrosion assessment <\/td>\n<\/tr>\n | ||||||
88<\/td>\n | Annex sec_M.4 Annex sec_M.5 Annex sec_M.6 <\/td>\n<\/tr>\n | ||||||
89<\/td>\n | Annex sec_M.7 Annex sec_M.8 <\/td>\n<\/tr>\n | ||||||
90<\/td>\n | Annex sec_N Annex sec_N.1 Annex sec_N.2 Annex sec_N.3 Annex sec_N.3.1 Annex sec_N.3.1.1 Annex sec_N.3.1.2 Annex sec_N.3.2 Annex sec_N.3.2.1 Annex sec_N.3.2.2 Annex sec_N.3.2.3 Annex sec_N.3.2.4 Annex sec_N.3.3 Annex sec_N.3.3.1 Annex\u00a0N \n(informative)<\/p>\n Guidelines for verification of hydrodynamic performance <\/td>\n<\/tr>\n | ||||||
91<\/td>\n | Annex sec_N.3.4 Annex sec_N.4 Annex sec_N.4.1 Annex sec_N.4.1.1 Annex sec_N.4.1.2 Annex sec_N.4.1.3 Annex sec_N.4.2 Annex sec_N.4.2.1 Annex sec_N.4.2.2 Annex sec_N.4.2.3 Annex sec_N.4.2.4 Annex sec_N.4.2.5 Annex sec_N.4.2.6 Annex sec_N.4.2.7 Annex sec_N.4.3 Annex sec_N.4.3.1 <\/td>\n<\/tr>\n | ||||||
92<\/td>\n | Annex sec_N.4.3.2 Annex sec_N.4.3.3 Annex sec_N.4.3.4 Annex sec_N.4.3.5 Annex sec_N.4.3.6 Annex sec_N.4.4 <\/td>\n<\/tr>\n | ||||||
93<\/td>\n | Annex sec_N.4.5 <\/td>\n<\/tr>\n | ||||||
94<\/td>\n | Annex sec_O Annex sec_O.1 Annex sec_O.2 Annex sec_O.3 Annex sec_O.4 Annex\u00a0O \n(informative)<\/p>\n Durability testing <\/td>\n<\/tr>\n | ||||||
95<\/td>\n | Annex sec_O.5 Annex sec_O.6 Annex sec_O.7 <\/td>\n<\/tr>\n | ||||||
96<\/td>\n | Annex sec_P Annex sec_P.1 Figure fig_P.1 Annex sec_P.2 Annex\u00a0P \n(informative)<\/p>\n Fatigue assessment <\/td>\n<\/tr>\n | ||||||
98<\/td>\n | Annex sec_P.3 Annex sec_P.3.1 Annex sec_P.3.2 <\/td>\n<\/tr>\n | ||||||
99<\/td>\n | Annex sec_P.3.3 Annex sec_P.3.4 Annex sec_P.3.5 <\/td>\n<\/tr>\n | ||||||
100<\/td>\n | Annex sec_P.4 Annex sec_P.4.1 Annex sec_P.4.2 Annex sec_P.4.3 Annex sec_P.4.4 <\/td>\n<\/tr>\n | ||||||
101<\/td>\n | Annex sec_P.4.5 Annex sec_P.4.6 Annex sec_P.4.7 <\/td>\n<\/tr>\n | ||||||
102<\/td>\n | Annex sec_Q Annex sec_Q.1 Annex sec_Q.2 Table tab_Q.1 Annex\u00a0Q \n(informative)<\/p>\n Preclinical in vivo evaluation <\/td>\n<\/tr>\n | ||||||
103<\/td>\n | Annex sec_Q.3 Annex sec_Q.3.1 Annex sec_Q.3.2 Annex sec_Q.3.3 Annex sec_Q.3.4 Annex sec_Q.3.5 Annex sec_Q.3.6 Annex sec_Q.3.7 <\/td>\n<\/tr>\n | ||||||
104<\/td>\n | Annex sec_Q.3.8 Annex sec_Q.3.9 Annex sec_Q.3.10 <\/td>\n<\/tr>\n | ||||||
105<\/td>\n | Annex sec_R Annex sec_R.1 Annex sec_R.2 Annex sec_R.3 Annex sec_R.4 Annex sec_R.5 Annex\u00a0R \n(normative)<\/p>\n Adverse event classification during clinical investigation <\/td>\n<\/tr>\n | ||||||
106<\/td>\n | Annex sec_R.6 Annex sec_R.7 Annex sec_R.7.1 Annex sec_R.7.2 <\/td>\n<\/tr>\n | ||||||
107<\/td>\n | Annex sec_R.8 <\/td>\n<\/tr>\n | ||||||
108<\/td>\n | Table tab_R.1 <\/td>\n<\/tr>\n | ||||||
109<\/td>\n | Annex sec_R.9 <\/td>\n<\/tr>\n | ||||||
110<\/td>\n | Annex sec_S Annex sec_S.1 Annex sec_S.1.1 Annex sec_S.1.2 Annex sec_S.1.3 Annex sec_S.1.4 Annex sec_S.1.5 Annex sec_S.1.6 Annex sec_S.1.7 Annex sec_S.2 Annex sec_S.2.1 Annex\u00a0S \n(informative)<\/p>\n Echocardiographic protocol <\/td>\n<\/tr>\n | ||||||
111<\/td>\n | Annex sec_S.2.2 Annex sec_S.2.3 Annex sec_S.3 Annex sec_S.3.1 Annex sec_S.3.2 Annex sec_S.3.3 Annex sec_S.3.4 Annex sec_S.3.5 Annex sec_S.3.6 <\/td>\n<\/tr>\n | ||||||
112<\/td>\n | Annex sec_S.3.7 Annex sec_S.3.8 Annex sec_S.4 <\/td>\n<\/tr>\n | ||||||
113<\/td>\n | Reference ref_1 Reference ref_2 Reference ref_3 Reference ref_4 Reference ref_5 Reference ref_6 Reference ref_7 Reference ref_8 Reference ref_9 Reference ref_10 Reference ref_11 Reference ref_12 Reference ref_13 Reference ref_14 Reference ref_15 Reference ref_16 Reference ref_17 Reference ref_18 Reference ref_19 Bibliography <\/td>\n<\/tr>\n | ||||||
114<\/td>\n | Reference ref_20 Reference ref_21 Reference ref_22 Reference ref_23 Reference ref_24 Reference ref_25 Reference ref_26 Reference ref_27 Reference ref_28 Reference ref_29 Reference ref_30 Reference ref_31 Reference ref_32 <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Cardiovascular implants. Cardiac valve prostheses – Heart valve substitutes implanted by transcatheter techniques<\/b><\/p>\n |